HIGHLIGHTS
- who: Luca G. Valente and collaborators from the Institute for Infectious Diseases, University of Bern, Bern, Switzerland, Department of Intensive Care have published the research work: Efficacy assessment of a novel endolysin PlyAZ3aT for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat model, in the Journal: PLOS ONE of January/13,/2022
- what: This study assessed the therapeutic potential of the novel endolysin PlyAZ3aT in an infant rat model of ceftriaxone-resistant pneumococcal meningitis.
- how: The authors investigated whether a novel phage lysine recently isolated from S. tigurinus strain AZ3aT . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.